ERBB2 and triple-negative breast carcinoma: Sempereet al. showed that ER+PR+HER2+, ER-PR-HER2+ and ER-PR-HER2- breast cancer tumors exhibited distinct miRNA patterns with expression of miR-205 in triple negative breast cancers correlating positively with clinical outcome.